We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Patent Office Affirms Revocation Of Viagra Patent

Law360 (February 10, 2005, 12:00 AM EST) -- A generic version of Pfizer’s erectile-dysfunction drug Viagra will reach the shelves of European drug stores after the European Patent Office decided to revoke a method-of-use patent for the drug, capping a seven-year battle between Pfizer and rival drug makers.

In a blow to Pfizer, the EPO affirmed its earlier decision to revoke Pfizer's method-of-use patent containing claims for the use of any PDE inhibitor for the manufacture of an oral treatment for erectile dysfunction.

The ruling was made following a three-day hearing by a Board...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.